Close Menu

A New Stage

The California Institute of Regenerative Medicine has a new strategic plan, reports the Nature News Blog. For the next five years, CIRM will shift its focus away from basic research toward clinical applications. "The first stage of CIRM was really exploring the field," says Ellen Feigal, the institute's senior vice president of R&D.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.